Anti-PD-1 Antibody Resistant
1 clinical trials · Condition
◉ Watch Anti-PD-1 Antibody Resistant
| Record | Firm | Date |
|---|---|---|
| The Clinical Trial of Chidamide+Decitabine+Camrelizumab Versus Decitabine+Camrelizumab in Anti-PD-1 Antibody Resistant Patients With Classical Hodgkin Lymphoma. (NCT04514081) | Chinese PLA General Hospital | 2020-08-01 |
Track Anti-PD-1 Antibody Resistant automatically
Every clearance here is in the API, with alerts when new ones post.